Document is current

Any future updates will be listed below

332 A CD70 armored Glypican-3 (GPC3) CAR-T therapy for treating advanced hepatocellular carcinoma

Crossref DOI link: https://doi.org/10.1136/jitc-2024-SITC2024.0332

Published Online: 2024-11-05

Published Print: 2024-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark